PIWIL1/HIWI Antibody (585509) [DyLight 405]
Novus Biologicals, part of Bio-Techne | Catalog # FAB6548E
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry
Label
DyLight 405 (Excitation = 400 nm, Emission = 420 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 585509
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human PIWIL1/HIWI
Arg82-Thr290
Accession # NP_004755
Arg82-Thr290
Accession # NP_004755
Specificity
Detects human PIWIL1/HIWI in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) PIWIL2 or rhPIWIL4 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for PIWIL1/HIWI Antibody (585509) [DyLight 405]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PIWIL1/HIWI
Long Name
Piwi-like Protein 1
Alternate Names
HIWI, MIWI
Gene Symbol
PIWIL1
Additional PIWIL1/HIWI Products
Product Documents for PIWIL1/HIWI Antibody (585509) [DyLight 405]
Product Specific Notices for PIWIL1/HIWI Antibody (585509) [DyLight 405]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...